Literature DB >> 17169395

CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.

Eli Boritz1, Eric L Rapaport, Thomas B Campbell, John R Koeppe, Cara C Wilson.   

Abstract

We previously detected HIV-1 Gag-specific CD4+ T cells recognizing reference strain viral epitopes in subjects with progressive, chronic infection. To test whether these CD4+ T cells persist in vivo by failing to recognize autologous HIV-1 epitopes, we compared autologous plasma HIV-1 p24 nucleotide sequences with targeted HXB.2 strain Gag p24 CD4+ T cell epitopes in nine chronically infected, untreated subjects. In five responding subjects, 10 of 26 HXB.2 strain p24 peptides targeted by CD4+ T cells exactly matched autologous plasma viral sequences. Four subjects with plasma viral loads >100,000 copies/mL had no measurable p24-specific CD4+ T cell responses despite carrying HIV-1 strains that matched HXB.2 sequences at predicted epitopes. These results show that HIV-1-specific CD4+ T cells can persist in chronic HIV-1 infection despite recognition of epitopes present in vivo. However, with high-level in vivo HIV-1 replication, CD4+ T cells targeting autologous HIV-1 may be non-responsive or absent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169395      PMCID: PMC5058783          DOI: 10.1016/j.virol.2006.10.040

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope.

Authors:  H Soudeyns; S Paolucci; C Chappey; M B Daucher; C Graziosi; M Vaccarezza; O J Cohen; A S Fauci; G Pantaleo
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

2.  Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.

Authors:  Nilufer Seth; Daniel Kaufmann; Timothy Lahey; Eric S Rosenberg; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

3.  HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.

Authors:  John R Koeppe; Thomas B Campbell; Eric L Rapaport; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-02-01       Impact factor: 3.731

4.  High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

Authors:  A C McNeil; W L Shupert; C A Iyasere; C W Hallahan; J A Mican; R T Davey; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses.

Authors:  S L Liu; T Schacker; L Musey; D Shriner; M J McElrath; L Corey; J I Mullins
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

Authors:  Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

8.  Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.

Authors:  Uma Malhotra; Sarah Holte; Tuofu Zhu; Elizabeth Delpit; Claire Huntsberry; Alessandro Sette; Raj Shankarappa; Janine Maenza; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Ablation of CD8 and CD4 T cell responses by high viral loads.

Authors:  Michael J Fuller; Allan J Zajac
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

10.  Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses.

Authors:  Beth D Jamieson; Otto O Yang; Lance Hultin; Mary Ann Hausner; Patricia Hultin; Jose Matud; Kevin Kunstman; Scott Killian; John Altman; Kristina Kommander; Bette Korber; Janis Giorgi; Steven Wolinsky
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

View more
  2 in total

1.  Can HIV p24 be a suitable scaffold for presenting Env antigens?

Authors:  Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

2.  Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.

Authors:  Adam J Ritchie; Suzanne L Campion; Jakub Kopycinski; Zoe Moodie; Z Maggie Wang; Kruti Pandya; Stephen Moore; Michael K P Liu; Simon Brackenridge; Kristin Kuldanek; Kenneth Legg; Myron S Cohen; Eric L Delwart; Barton F Haynes; Sarah Fidler; Andrew J McMichael; Nilu Goonetilleke
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.